|
Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany |
Thelen U, Schnober D, Scholzel S, Kristoffersen MS, Nelson LA, Stewart JA, Stewart WC |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Thelen U, Schnober D, Scholzel S, Kristoffersen MS, Nelson LA, Stewart JA, Stewart WC. Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany. International Journal of Ophthalmology 2013; 6(2): 155-159 Indexing Status Subject indexing assigned by CRD MeSH Antihypertensive Agents; Cost-Benefit Analysis; Germany; Glaucoma, Open-Angle; Humans; Prostaglandins F, Synthetic; Timolol AccessionNumber 22013020061 Date bibliographic record published 10/06/2013 |
|
|
|